AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2021
Feb 1, 2021
3174_iss_2021-02-01_94a97221-24e4-4447-8f7f-b23f100e0310.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Nordnet AB (publ)
Instrument
| Before the transaction Shares 2,514,343 Voting rights 2,514,343 Transaction Reason for major shareholding notification Corporate action Date 29/01/2021 Limit for number of shares 10 % Limit for number of votes 10 % After the transaction Quantity Shares 2,448,211 Directly held voting rights 0 Indirectly held voting rights 2,448,211 Percentage Directly held shares 5.49 % |
Instrument | Aktier SE0013121340 |
|---|---|---|
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 5.49 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.49 % | 2,448,211 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5.49 % | 2,448,211 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||||
|---|---|---|---|---|
| 2,351,387 5.27 | Nordnet Pensionsförsäkring AB | |||
| 96,824 | 0.22 | Nordnet Livsforsikring AS | ||
| Group total holdings | ||||
| Voting rights | 2,448,211 | |||
| Percentage of voting rights 5.49 |
Notes (other relevant informations according to law)
Nordnet AB (publ) genom Nordnet Pensionsförsäkring AB och Nordnet Livsforsikring AS har underskridit tröskelvärdet 10% av antalet utestående aktier och röster till följd av nytt antal utestående aktier och röster.
Published
01/02/2021 13:31
Contact
Name Max Rhodin Edlund Phone +46730487570 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13